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Analysis of Cigarette-Smoke-Induced DNA
Adducts by Butanol Extraction and Nuclease
P1-Enhanced 32P-Postlabeling in Human
Lymphocytes and Granulocytes
by Kirsti Savela1 and Kari Hemminki2
Inanearlierstudy, weanalyzedthearomatic DNAadductsseparatedfromlymphocytes andgranulocytes of
smokersandnonsmokers usingthenucleaseP1-enhanced32P-postlabelingassay.Herewecomparethebutanol
extraction and nuclease P1-enhanced procedure on the same kind ofsamples. The DNA adducts of42 per10i
nucleotides fromsmokers' lymphocytes were statistically higher(p < 0.05) thanthoseof11from nonsmokers',
when analyzed by the nuclease P1 treatment, but not by the 1-butanol extraction. The radioactivity obtained
fromtheDNAdigests ontheTLCplates waslowerinbutanol-treatedDNAsampleswhencomparedtothoseof
nuclease P1 digestion. Lymphocytes appear to be a suitable test tissue for determining aromatic carcinogen
exposurewhendetectingsmoking-relatedDNAadductsbythenucleaseP1-enhanced32P-postlabelinganalysis.
Introduction
Carcinogen-DNA adducts are currently considered a
useful biological marker in risk assessment for potential
environmental carcinogens (1). Cigarette smoking is a
major cause of lung cancer and other diseases, and it is
also an important source of exposure to polycyclic aro-
matic hydrocarbons (PAHs), aromatic amines, and
tobacco-specific nitrosoamines (2-4). Carcinogenic PAHs
ofcigarette smoke were analyzed by the 32P-postlabeling
assay from various human tissues, and the complexity of
the adduct formation was shown in target and nontarget
tissues (5-9). Although the chromatographic profiles
obtained by the 32P-postlabeling technique were charac-
teristic for aromatic compounds [benzo[a]pyrene; (8,10)],
theiridentificationisonlywellverifiedinanimals(11). In an
earlier study we separatedlymphocytes and granulocytes
of smokers and nonsmokers and analyzed aromatic DNA
adducts by the nuclease P1-enhanced 32P-postlabeling
assay (12). This study was carried out with the same
lymphocyte and granulocyte DNA samples to investigate
whether there are differences between thebutanol extrac-
tion and the nuclease P1 enhancement procedures before
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32P-postlabeling in determining the smoking-related
adducts.
Materials and Methods
Smokers and controls blood sampling, DNA isolation,
nuclease P1-enhanced 32P-postlabeling analysis, solvents
used for the chromatographic purification, and the quan-
tification of adduct levels are described elsewhere (12).
Four micrograms of lymphocyte DNA from 10 smokers
and 8 nonsmokers and granulocyte DNAfrom 10 smokers
and from 9nonsmokersweretreatedwiththemicrococcal
nuclease (MN; 0.16 U) and spleen phosphodiesterase
(SPD; 1.6 ,ug) at 37°C for 3.5 hr and treated with the
nuclease P1 (3 ,ug at 370C for 40 min) according to the
method of Reddy and Randerath (13). Butanol extraction
was carried out according to the procedure ofGupta (14).
Afterthe incubationwith MN and SPD, the DNA digests
were diluted to 40 ,L1 by adding water (DNA concentra-
tion 0.1 ,ug/,uL). For the extraction of adducts, 5 ,ul of 10
mMtetrabutylammonium chloride (TBA), 5 ,LL of100mM
ammonium formate, pH 3.5, and 80 ,uL water were added
(total volume 130 ,LL). The mixture was extracted two
times with water-saturated 1-butanol (130 ,L) by mixing
in a vortex 30 sec. The phases were separated by centri-
fuging for 30 sec in a microcentrifuge, and the butanol
phases were combined (total volume about 260 ,LL). The
butanol extract, first back-extracted two times with the
1-butanol-saturated water, was adjusted with 2.5 pLL ofSAVELA AND HEMMINKI
FIGURE 1.Autoradiograms of32P-labeled DNAadductsfromlymphocytesandgranulocytes ofsmoker. Lymphocyte DNAofmalesmokersanalyzedby
(a,b) butanol extraction and (c,d) nuclease P1 treatment. Autoradiography was at -70°C for 3.5 days. Circles marked "x" on panels a and b are the
background spots, and the three open circles on panel c are smoking-specific adducts also obtained from the samples in a previous study (12).
200 mM Tris-HCl to pH 9.5 and evaporated in Speed-Vac
(Savant Instruments Inc.). Calfthymus DNA (4 ,ug) and
7R,8S,9S-trihydroxy-10R-(N2-deoxyguanosyl-3'-mono-
phosphate)7,8,9,10-tetrahydrobenzo[a]pyrene (BPDG-dG;
Midwest Research Institute, Kansas City, MO) was used
as a reference compound in the labeling analysis. 32p-
postlabeling was carried out for the DNA samples two to
three times with 30 ,uCi of commercially prepared
[y-32P]ATP (10 pmole; 3000 Ci/mmole; Amersham)], 33
pmole ofcold ATP and 4 U ofT4polynucleotide kinase in
the kinasebuffer, pH 9.8, for40min at37°C as detailedby
Savela and Hemminki (12).
Results
Figure 1 shows the autoradiograms obtained by the
butanol- and nuclease P1-enriched 32P-postlabeling anal-
ysis from the same male smokers' lymphocyte and gran-
ulocyte DNA, respectively. Lymphocyte DNAobtainedby
butanol extraction showed a radioactive zone going up to
therightcorner, consistingofseveralfaintspots (Fig. la).
The granulocyte DNA of the same smoker showed only
few radioactive spots on the autoradiograms when DNA
was analyzed by the butanol extraction (Fig. lb). The
intensity ofradioactivitywas higher in smokers' lympho-
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FIGURE 2.32P-labeled calfthymusDNAanalyzedby(a)butanoland (b)nucleaseP1 treatment. Circlemarkedby"x"isthebackground spotobtainedby
the butanol extraction. Autoradiography was at -70°C for 3.5 days.
cyte DNAanalyzedbythenuclease P1 treatment (Fig. lc)
compared to that analyzed bythe butanol extraction (Fig.
la).Figure lcshowsthesmoking-specificadductsdetected
in the previous study also (12). The radioactivity was very
low on the autoradiograms obtained from granulocyte
DNAofsmokersbynucleaseP1 enhanced32P-postlabeling
(Fig. ld). Acircle marked as anx-spotinthemiddle ofthe
autoradiograms from smoker's lymphocytes indicates the
background spot (Fig. la,b). These x-spots were also
obtained when calf thymus DNA was analyzed by the
butanol extraction procedure (Fig. 2a), but not by the
nuclease P1 treatment (Fig. 2b).
The intensity of the spots on the autoradiograms
obtained from the lymphocyte and granulocyte DNA of
nonsmokers showed very low radioactivity when treated
both with nuclease P1 and butanol extraction before 32p-
postlabeling (Fig. 3a-d). Nonsmokers' lymphocyte DNA
(Fig. 3a), but not granulocyte DNA, also showed the
similar background x-spot that was obtained from
smokers' lymphocyte and granulocyte DNA extracted by
butanol (Fig. la,b).
The levels of adducts ranged from 4 to 32 per 108
nucleotides in lymphocytes of both smokers and non-
smokers after butanol extraction and from 16 to 98 in
smokers and from 15 to 28 in nonsmokers when analyzed
by nuclease P1-enhanced 32P-postlabeling (Table 1). The
levels ofadducts were lowin granulocytes, rangingfrom4
to 13 per 108 nucleotides in smokers and from 3 to 13 in
nonsmokers after butanol extraction, and from 4 to 14 in
smokers andfrom5to19innonsmokers afternuclease P1-
enhanced procedure (Table 1). The mean number of DNA
adducts/108 nucleotides detected fronm smokers' and non-
smokers' lymphocytes and granulocytes are presented in
Figure4. The errorbarsindicate the standarddeviationof
the two to three mean parallel 32P-postlabeled experi-
ments. The total DNA adduct levels of 42 + 7.5/108
nucleotides from smokers' lymphocyteswere significantly
higher than those of 22 ± 1.9/108 nucleotides from non-
smokers, when analyzed by the nuclease P1-enhanced
postlabeling assay(Table2). Thebutanol extraction analy-
sis yielded from the smokers' lymphocytes 20 + 7.5 and
from those nonsmokers' lymphocytes 13 + 3.1 DNA
adducts per 108 nucleotides (Table 1). The total DNA
adduct levels in granulocytes, when analyzed by both the
butanol extraction and nuclease P1-enhanced 32p-
postlabeling, were statistically lower (p < 0.05) compared
tothoseoflymphocytes,butshowednostatisticallysignifi-
cant difference between smokers' and nonsmokers' gran-
ulocyte DNA adduct levels (Table 2).
Figure 5 shows the comparison of DNA adduct levels
from the lymphocytes of 10 smokers when analyzed by
nuclease P1-enhanced 32P-postlabeling in years 1990 and
1991. The relationship of the adduct levels was relatively
good, although not statistically significant (y = 0.74x +
20.5, r = 0.55, n = 10).
Discussion
As the nuclease P1 enzyme is thought to dephosphory-
late the adducted mononucleotides formed by tobacco-
specific nitrosoamines and aromatic amines bound to the
C-8 position ofguanine, butanol extraction is an alterna-
tive method of detecting adducts formed by cigarette
smoke (14-16).Whenbutanol extractionwas applied tothe
DNA samples, all backgrounds of the TLC plates were
clean (Fig. la,b compared to c,d), suggesting thatbutanol
did not extract some minor adducts. Overall, lower DNA
adduct levels were obtained from smokers' lymphocytes
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FIGURE 3. Autoradiograms obtained by the 32P-labeling of DNA from lymphocyte and granulocyte of male nonsmoker. Lymphocyte DNA of a
nonsmoker analyzed by (a,b) butanol extraction and (c,d) nuclease P1 treatment. Autoradiography was at -70°C for 3.5 days.
and granulocytes by the butanol extraction than by the
nuclease P1 treatment, perhaps suggestinglowerlevels of
P1-sensitive nitroaromatic and aromatic amine DNA
adducts than stable PAH-type adducts (16). Possible rea-
sons for lower adduct levels could also be the loss of
material duringthebutanol extraction steps and discrimi-
nating anyadducted dinucleotides. Yet, aslongasthe 32p-
postlabeled adducts remain unidentified, it is difficult to
assess the selectivity ofthe two methods (14,16,17).
A statistically significant difference was obtained
betweenthetotalDNAadductlevelsbetweenthesmokers'
andnonsmokers'lymphocytes analyzedbythenucleaseP1
procedure only (Table 2). The relationship of the adduct
data from smokers' lymphoctes was studied, with the
results obtained with the same samples in 1990 (Fig. 5).
The results of this study confirm the same levels of
adducts determined by the nuclease P1-enhanced 32P-
postlabeling analysis in the 2 years (12). The adduct data
are also in accordance, irrespective of the pretreatment,
withthe higher DNAadductlevels inlymphocytes than in
granulocytes of smokers. The 32P-postlabeled total white
blood cell DNA adducts has been used in several occupa-
tional studies as an indicator of PAH exposure. By con-
trast, no effect ofsmoking was seen in these studies (18-
20).Thehumanlymphocytesarethusmoresuitableforuse
in determining the effect of smoking or, perhaps, in
humans occupationally or environmentally exposed to
PAHs (12,21).
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Table 1. Summary data ofDNA adducts analyzed by the butanol extraction and nuclease P1 enhanced 32P-postlabeling.
Adducts/108 nucleotides ± SE
Butanol extraction Nuclease P1 treatment
Subjects Lymphocytes Granulocytes Lymphocytes Granulocytes
Smokers
1 32 14 13 ± 5.6 34 ± 7.5 8.7 ± 3.4
2 24 0.5 10 ± 5.7 57a 11 ± 5.3
3 24a 5± 0.0 98a 8.0 ± 0.9
4 25 ± 5.0 6.8 ± 1.3 45 ± 9.0 9.7 ± 6.3
5 21 ± 11 8.0 ± 0.2 38 ± 18 4.2 ± 1.5
6 30 ± 10 12 ± 2.6 14 ± 1.9 12 ± 3.4
7 8.0 ± 2.9 8.9 ± 1.8 35 ± 19 14 ± 2.5
8 22 ± 6.2 11 ± 6.9 33 ± 10 7.8 ± 2.3
9 3.9 ± 0.5 5.9 ± 1.5 16 ± 4.6 11 ± 3.5
10 7.0 ± 1.4 4.1 ± 1.3 48 ± 25 10 ± 3.5
Nonsmokers
1 20 ± 4.0 5.6 ± 0.6 23 ± 1.5 10 ± 7.0
2 32 ± 6.0 3.4 ± 1.2 21 ± 0.5 4.9 ± 1.5
3 10 ± 0.6 4.8 ± 1.8 27 ± 1.0 12 ± 7.9
4 8.1 ± 1.9 - 19 ± 3.5
5 9.9 ±4.1 11 ± 2.7 28 ± 7.6 7.2 ± 0.8
6 11 3.8 8.0 3.8 18 7.4 9.7 5.4
7 8.0 3.6 13 5.3 15 3.2 13 2.7
8 11 2.2 7.4±2.4 28±6.4 14±3.4
9 4.5 1.5 6.1 0.6 15 4.8 8.6 1.4
aOnly one postlabeling experiment. Otherwise, adduct levels are given as a mean number ofadducts oftwo to three32P-postlabelings.
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FIGURE 4. Bar chart of the mean adduct levels obtained from lymphocytes and granulocytes of smokers and nonsmokers analyzed by butanol and
nuclease P1-enhanced 32P-postlabeling.
Table 2. DNA adducts analyzed from lymphocytes and granulocytes ofsmokers and nonsmokers
by butanol extraction and nuclease P1 enhanced 32P-postlabeling assay.
Adducts/108 nucleotides ± SE
Smokers Nonsmokers
Method Lymphocytes Granulocytes Lymphocytes Granulocytes
Butanol extraction 20 + 3.1 8.6 + 0.9 13 + 3.1 7.4 + 1.1
Nuclease P1 treatment 42 + 7.5* 9.7 ± 0.9 22 + 1.9 11 + 1.4
*P < 0.05 analyzed bytwo-tailed Students t-test; t-value between DNAadducts ofsmokers' and nonsmokers' lymphocytes is 2.3, when analyzed by
nuclease P1 enhanced 32P-postlabeling.
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FIGURE 5. Relationship between the DNA adducts/108 nucleotides ana-
*lyzed from smokers' lymphocytes in 1990 and 1 year later. The pair of
dottedlines represent the 95% confidence limit. Degrees offreedom = 8,
correlation coefficients = 0.55, p = 0.07.
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